Open AccessWhat Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?
Author(s) -
Jeffrey D. Lebensburger,
Michael R. DeBaun,
Alexis A. Thompson
Publication year - 2011
Publication title -
hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.321
H-Index - 91
eISSN - 1520-4391
pISSN - 1520-4383
DOI - 10.1182/asheducation-2011.1.440
Subject(s) - medicine , stroke (engine) , hemoglobin , presentation (obstetrics) , pediatrics , secondary prevention , surgery , mechanical engineering , engineering
A 10-year-old male patient with hemoglobin SS suffered a stroke at 7 years of age and was initially transfused at the time of presentation to lower the hemoglobin S concentration to < 30%. You are asked by the family if their child can be treated with oral hydroxyurea rather than monthly transfusions for the secondary prevention of strokes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom